Teicoplanin Injection IP is a powerful glycopeptide antibiotic used primarily to treat severe and complicated bacterial infections caused by Gram-positive bacteria. It is especially critical in hospital settings for treating Methicillin-resistant Staphylococcus aureus (MRSA) and for patients who are allergic or unresponsive to penicillins.
Primary Uses
Teicoplanin is indicated for the treatment of both uncomplicated and complicated infections, including:
- Skin and Soft Tissue Infections: Complex infections of tissue, wounds, or ulcers.
- Bone and Joint Infections: Conditions like osteomyelitis (bone infection) and septic arthritis.
- Cardiovascular Infections: Infective endocarditis (inflammation of the heart lining).
- Pneumonia & Blood Infections: Severe cases of bacteremia (bacteria in the blood stream) and community-acquired or ventilator-associated pneumonia.
- Urinary & Abdominal Infections: Severe urinary tract infections and peritonitis (often associated with dialysis).
- Surgical Prophylaxis: Used as a preventative measure in orthopedic or other surgeries at high risk of Gram-positive infections.
